Ekimas Corp ASNB
We take great care to ensure that the data presented and summarized in this overview for EKIMAS Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in ASNB
Top Purchases
Top Sells
About ASNB
EKIMAS Corporation does not have significant operations. Previously, the company was engaged in the development of polymer materials for use in the design and development of medical devices used for treating a range of anatomical sites and disease states. It intends to identify, acquire, or merge with an operating company through an equity-based exchange transaction. The company was formerly known as AdvanSource Biomaterials Corporation and changed its name to EKIMAS Corporation in March 2020. EKIMAS Corporation was incorporated in 1993 and is based in Las Vegas, Nevada.
Insider Transactions at ASNB
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 16
2024
|
Gk Partners Ap S > 10% Shareholder |
SELL
Open market or private purchase
|
Direct |
121,555
-0.54%
|
$121,555
$1.0 P/Share
|
|
Aug 05
2024
|
Gk Partners Ap S > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
30,000
+0.13%
|
$30,000
$1.0 P/Share
|
|
Jul 18
2024
|
Gk Partners Ap S > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
100,000
+0.44%
|
$100,000
$1.0 P/Share
|
|
Jul 05
2024
|
Gk Partners Ap S > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
30,000
+0.13%
|
$30,000
$1.0 P/Share
|
|
May 30
2024
|
Gk Partners Ap S > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
30,000
+0.13%
|
$30,000
$1.0 P/Share
|
|
May 14
2024
|
Gk Partners Ap S > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
20,106,062
+47.36%
|
$20,106,062
$1.0 P/Share
|
|
Apr 29
2024
|
Gk Partners Ap S > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
30,000
+1.32%
|
$30,000
$1.0 P/Share
|
|
Mar 20
2024
|
Gk Partners Ap S > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
250,000
+10.14%
|
$250,000
$1.0 P/Share
|
|
Mar 20
2024
|
Henrik Rouf CEO |
SELL
Open market or private sale
|
Direct |
250,000
-29.94%
|
$250,000
$1.0 P/Share
|
|
Mar 14
2024
|
Gk Partners Ap S > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
25,000
+1.26%
|
$25,000
$1.0 P/Share
|
|
Jan 31
2024
|
Gk Partners Ap S > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
46,000
+2.32%
|
$46,000
$1.0 P/Share
|
|
Jan 15
2024
|
Gk Partners Ap S > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,701,527
-47.31%
|
$0
$0.97 P/Share
|
|
Jan 11
2024
|
Gk Partners Ap S > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
55,000
+1.51%
|
$55,000
$1.0 P/Share
|
|
Dec 19
2023
|
Gk Partners Ap S > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
25,000
+0.7%
|
$25,000
$1.0 P/Share
|
|
Dec 14
2023
|
Gk Partners Ap S > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
8,500
+0.24%
|
$8,500
$1.0 P/Share
|
|
Nov 28
2023
|
Gk Partners Ap S > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
25,000
+0.71%
|
$25,000
$1.0 P/Share
|
|
Oct 30
2023
|
Gk Partners Ap S > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
10,000
+0.29%
|
$10,000
$1.0 P/Share
|
|
Oct 19
2023
|
Gk Partners Ap S > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
15,000
+0.43%
|
$15,000
$1.0 P/Share
|
|
Oct 02
2023
|
Gk Partners Ap S > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
500,000
+12.63%
|
$500,000
$1.0 P/Share
|
|
Sep 28
2023
|
Gk Partners Ap S > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
15,000
+0.5%
|
$15,000
$1.0 P/Share
|
Last 12 Months Summary
| Other acquisition or disposition | 20.1M shares |
|---|---|
| Open market or private purchase | 655K shares |
| Open market or private sale | 1.95M shares |
|---|---|
| Open market or private purchase | 122K shares |